<DOC>
	<DOCNO>NCT02062190</DOCNO>
	<brief_summary>Resveratrol supplementation may improve cardiovascular risk factor cognitive parameter patient schizophrenia take antipsychotic ?</brief_summary>
	<brief_title>Resveratrol , Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia</brief_title>
	<detailed_description>Randomized , double-blind , placebo-controlled trial compare supplementation resveratrol placebo patient diagnose schizophrenia .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Resveratrol</mesh_term>
	<criteria>Men 1865 year old , diagnose schizophrenia accord DSMIV ICD10 , clozapine medication least 6 month . Patients exclude study : Have diagnosis diabetes Use antipsychotic drug , clozapine beyond Using medicine diabetes dyslipidaemia Accept participate stage research .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>